Regulation of Papillomavirus DNA Replication
乳头瘤病毒 DNA 复制的调控
基本信息
- 批准号:6456992
- 负责人:
- 金额:$ 13.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-10 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Cancer of the uterine cervix is one of the
few human cancers known to be caused by a specific virus, the human
papillomavirus. Despite its known etiology, there are no effective antiviral
agents or vaccines to prevent or halt an infection and its progression to
cervical cancer. A firm understanding of papillomavirus biology is essential in
order to understand specific mechanisms of cancer induction, find methods to
prevent infections, and gain insights into the biology of normal and cancer
cells.
The major objective of the proposed research is to understand mechanisms used
by papillomaviruses to regulate their DNA replication. This proposal focuses on
the activity of the major viral replication protein, El, and the role of
phosphorylation in regulating El function. To fulfill this primary objective,
two specific aims will be addressed: one, determine the replication phenotype
of phosphorylation defective El mutant viral genomes; and two, analyze purified
wild-type and mutant El proteins for biochemical activities and defects.
To accomplish these research objectives, a combination of genetic and
biochemical approaches will be used. Mutations will be introduced at sites that
are phosphorylated on the El protein, and El mutant viral genomes will be
analyzed for their replication phenotype in mammalian cells. El proteins that
result in replication defects will be expressed in mammalian or insect cells
and purified. Wild-type and mutant El proteins will be analyzed for specific El
functions, including replication origin DNA binding, helicase enzyme activity,
and binding to cellular DNA polymerase.
This work will contribute significant new information to the fields of
papillomavirus biology and DNA replication, and offer new insights into the
unique properties of viral latency.
描述(由申请人提供):子宫颈癌是一种
已知由特定病毒引起的少数人类癌症,人类
乳头瘤病毒尽管其病因已知,但没有有效的抗病毒药物
预防或阻止感染及其进展的药剂或疫苗,
宫颈癌对乳头状瘤病毒生物学的深刻理解对于
为了了解癌症诱导的具体机制,找到方法,
预防感染,并深入了解正常和癌症的生物学
细胞
拟议研究的主要目标是了解使用的机制
来调节它们的DNA复制该提案的重点是
主要病毒复制蛋白El的活性,以及
磷酸化调节E1功能。为了实现这一主要目标,
将解决两个具体目标:一,确定复制表型
磷酸化缺陷El突变病毒基因组;和二,分析纯化的
野生型和突变型E1蛋白的生化活性和缺陷。
为了实现这些研究目标,遗传和
将使用生物化学方法。突变将在
在El蛋白上被磷酸化,El突变病毒基因组将被磷酸化。
分析它们在哺乳动物细胞中的复制表型。El蛋白质,
导致复制缺陷的基因将在哺乳动物或昆虫细胞中表达
并被净化将分析野生型和突变型El蛋白的特异性El
功能,包括复制起点DNA结合,解旋酶活性,
并与细胞DNA聚合酶结合。
这项工作将为以下领域提供重要的新信息:
乳头瘤病毒生物学和DNA复制,并提供新的见解,
病毒潜伏期的独特特性
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A phosphorylation map of the bovine papillomavirus E1 helicase.
牛乳头瘤病毒 E1 解旋酶的磷酸化图谱。
- DOI:10.1186/1743-422x-3-13
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Lentz,MichaelR;StevensJr,StanleyM;Raynes,Joshua;Elkhoury,Nancy
- 通讯作者:Elkhoury,Nancy
Phosphorylation of bovine papillomavirus E1 by the protein kinase CK2 near the nuclear localization signal does not influence subcellular distribution of the protein in dividing cells.
- DOI:10.1007/s00705-015-2641-6
- 发表时间:2016-01
- 期刊:
- 影响因子:2.7
- 作者:Lentz MR;Shideler T
- 通讯作者:Shideler T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R LENTZ其他文献
MICHAEL R LENTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R LENTZ', 18)}}的其他基金
REGULATION OF BPV E1 PROTEIN ACTIVITY BY PHOSPHORYLATION
通过磷酸化调节 BPV E1 蛋白活性
- 批准号:
2594516 - 财政年份:1993
- 资助金额:
$ 13.38万 - 项目类别:
REGULATION OF BPV E1 PROTEIN ACTIVITY BY PHOSPHORYLATION
通过磷酸化调节 BPV E1 蛋白活性
- 批准号:
3460710 - 财政年份:1993
- 资助金额:
$ 13.38万 - 项目类别:
REGULATION OF BPV E1 PROTEIN ACTIVITY BY PHOSPHORYLATION
通过磷酸化调节 BPV E1 蛋白活性
- 批准号:
2100030 - 财政年份:1993
- 资助金额:
$ 13.38万 - 项目类别:
REGULATION OF BPV E1 PROTEIN ACTIVITY BY PHOSPHORYLATION
通过磷酸化调节 BPV E1 蛋白活性
- 批准号:
2100031 - 财政年份:1993
- 资助金额:
$ 13.38万 - 项目类别:
REGULATION OF BPV E1 PROTEIN ACTIVITY BY PHOSPHORYLATION
通过磷酸化调节 BPV E1 蛋白活性
- 批准号:
2100029 - 财政年份:1993
- 资助金额:
$ 13.38万 - 项目类别: